Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Submit a comment

3,3′-Diiodothyronine Production, a Major Pathway of Peripheral Iodothyronine Metabolism in Man
Laurence A. Gavin, … , James N. Castle, Ralph R. Cavalieri
Laurence A. Gavin, … , James N. Castle, Ralph R. Cavalieri
Published May 1, 1978
Citation Information: J Clin Invest. 1978;61(5):1276-1285. https://doi.org/10.1172/JCI109044.
View: Text | PDF
Research Article

3,3′-Diiodothyronine Production, a Major Pathway of Peripheral Iodothyronine Metabolism in Man

  • Text
  • PDF
Abstract

3,3′-Diiodothyronine (3,3′-T2) has been detected in human serum and in thyroglobulin. However, no quantitative assessment of its clearance rate (CR), production rate (PR), or of the importance of extrathyroidal sources of 3,3′-T2 relative to direct thyroidal secretion is yet available. This study examines these parameters in seven euthyroid subjects, and in eight athyreotic subjects (H) eumetabolic due to thyroxine therapy (HT4) (n = 5) or triiodothyronine replacement (HT3) (n = 3). A highly specific radioimmunoassay for the measurement of 3,3′-T2 in whole serum was developed. Serum 3,3′-T2 concentrations were (mean ± SD) 6.0±1.0 ng/100 ml in 13 normal subjects, 9.0±4.6 ng/100 ml in 25 hyperthyroid patients, and 2.7±1.1 ng/100 ml in 17 hypothyroid patients. The values in each of the latter two groups were significantly different from normal. 3,3′-T2 was detected regularly in normal concentrations in 11 hypothyroid patients eumetabolic by treatment with synthetic T4, in 10 eumetabolic patients suffering from nonthyroidal systemic illness, and in 2 subjects with elevated serum T4-binding globulin. The 3,3′-T2 CR was assessed from data acquired from the 125I-3,3′-T2 constant infusion technique. The 3,3′-T2 PR was calculated from CR and serum concentration of 3,3′-T2 determined by radio-immunoassay. In the HT4 subjects the 3,3′-T2 CR averaged 840±377 liters/day and 3,3′-T2 PR 33.9±12.5 μg/day. These results were not significantly different from those in the control group: 3,3′-T2 CR 628±218 liters/day and 3,3′-T2 PR 39.8±19.8 μg/day (all corrected to 70 kg body wt). In addition to 3,3′-T2 PR, T3, and reverse triiodothyronine (rT3) PR were determined in three of the HT4 subjects. In each case studied, the 3,3′-T2 PR was close to the combined triiodothyronine (T3 + rT3) PR. The mean molar ratio of T2 PR/(T3 + rT3) PR was 1.08±0.10. The results obtained in the HT4 subjects indicate that the production of 3,3′-T2 is a major route of T4 metabolism. The combined studies of 3,3′-T2, T3 and rT3 PR in the HT4 subjects indicate that both T3 and rT3 are major precursors of 3,3′-T2. In the HT3 subjects, the conversion of T3 to 3,3′-T2, determined as the molar ratio of 3,3′-T2 PR to T3 PR, ranged from 0.36 to 0.92, providing further evidence that T3 is a precursor of 3,3′-T2. From the close agreement between the mean values for 3,3′-T2 PR in the euthyroid and HT4 group it is concluded that most, if not all of the 3,3′-T2 produced in normal humans is derived by extrathyroidal conversion from T3 and rT3.

Authors

Laurence A. Gavin, Margaret E. Hammond, James N. Castle, Ralph R. Cavalieri

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts